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Abstract Theobjective ofthis studywas to describethepulmonary function andpain 4months aftercoronaryartery
bypass graft surgery. Twenty-five male patients performed pulmonary function tests before surgery, on the 4th
postoperative day and 4 months after surgery. A severe reduction in pulmonary function was present after surgery.
Four months postoperatively, the patients still showed a significant decrease (6^13% of preoperative values) in vital
capacity (Po0.001), inspiratory capacity (Po0.001), forced expiratory volume in 1s (Po0.001), peak expiratory flow
rate (Po0.001), functional residual capacity (P= 0.05), total lung capacity (Po0.001) and single-breath carbon
monoxide diffusing capacity (Po0.01). Residual volume and single-breath carbon monoxide diffusing capacity per
litre of alveolar volume had returned to the preoperative level. Four months postoperatively, the median values for
sternotomy pain while taking a deep breath was 0.2 and while coughing 0.3 on a 10 cm visual analogue pain scale.
In conclusion, a significant restrictive pulmonary impairment persisting up to 4 months into the postoperative
period was found after CABG.Measured levels of pain were low and could not explain the impairment.r 2003 Elsevier
Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1424, available online at http://www.sciencedirect.com
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Patients undergoing coronary artery bypass graft sur-
gery (CABG) often develop atelectasis and severe reduc-
tions in lung volumes and oxygenation (1,2) in the early
postoperative period.The reason for the pulmonary im-
pairment is multifactorial and may be due to e¡ects of
anaesthesia, intra-operative events, mechanical altera-
tions, diaphragmatic dysfunction, medication and the pa-
tients’ postoperative heamodynamic status (3^5).
Postoperative pain contributes to the pulmonary dys-
function. The sternotomy causes considerable pain and
may persist for years after surgery (6).Received 22 March 2002, accepted in revised form 5 July 2002
Correspondence should be addressed to: RPT ElisabethWesterdahl,
Department of Physiotherapy,)rebro University Hospital, SE-70185
)rebro, Sweden.Fax: +4619 602 5778;
E-mail: elisabeth.westerdahl@orebroll.seDecreased pulmonary function and sternotomy pain
in the early period after cardiac surgery are common
and well described. Comparatively few studies have
evaluated the long-term e¡ects on pulmonary function
(7^11). The decrease in pulmonary function 3^4
months after surgery has been described 10^20 years
ago by Braun et al. (7) and Shapira et al. (9). The only
recent publication on this topic is Shenkman et al. (11)
who reported signi¢cantly decreased dynamic lung
volumes and expiratory £ow rates 14 weeks after
cardiac surgery.The investigation did not include an eva-
luation of static lung volumes. A presentation of com-
plete pulmonary function tests in the long-term period
in patients undergoing CABGhas not been presented in
recent years.
The aimof thepresent study was to describe the long-
term alterations of pulmonary function and to describe
postoperative pain after CABG.
TABLE 1. Demographic data
Variables
Age (years) 65.679.7
BMI (kg/m2) 26.573.1
Never smoked/ smokers (n) 9/16
NYHAclass II/IIIA/IIIB (n) 6/13/6
Left ventricular ejection fraction (%) 62.9713.2
Values aremean7SD ornumberof patients.
BMI = bodymassindex,NYHA=NewYorkHeart Asso-
ciation, n= numberof patients.
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A total of 30 male CABG patients were selected from a
previous investigation (12) at )rebro University Hospi-
tal. Consecutively the ¢rst 30 patients, living within
50km from the hospital, were enrolled in the study. Pa-
tients who hadunstable angina, previous cardiac surgery
or severe renal dysfunctionwere not included.The study
was approved by the Research Ethics Committee in )r-
ebro and informed consent was obtained from each pa-
tient.
All patients received general anaesthesia and CABG
was performed with cardiopulmonary bypass through a
median sternotomy. Saphenous vein grafts and/or left or
right internal mammary artery graft was used. Pericar-
dial, mediastinal and generally one or both pleura were
drained, less than 24h after surgery.Cold blood cardio-
plegia and pericardial cooling with ice were used and an
insulation pad was used to protect the phrenic nerve.
The patients’ lungs were kept de£ated during the aortic
clamping. Postoperatively, the patients were ventilated
with a positive end-expiratory pressure of 5 cmH2O
and an inspired oxygen concentration of 60^80%. After
extubation, all patients received pain relief with mor-
phine and paracetamol according to their needs along
with routine postoperative protocol.
Thepatients receivedbasic postoperative care as con-
ventionally used at the hospital.The patients weremobi-
lized as early as possible and were given chest
physiotherapy including exercises of the upper limbs
and thorax and instructions in deep breathing and
coughing. All patients were instructed to perform
30 deep breaths with or without a mechanical device
once an hour at daytime, as described in detail else-
where (12).
Pulmonary function measurements were performed,
in a sitting position, preoperatively, on the 4 postopera-
tive day and 4 months postoperatively with a Medical
Graphics PF/Dx Pulmonary Function System (Spirophar-
maA/S,Denmark).ReferencevaluesreportedbyGrimby
and S˛derholm (13) were used.The highest value of two
or three technically satisfactory manoeuvres was re-
tained for measurement of vital capacity (VC), inspira-
tory capacity (IC), forced expiratory volume in1s (FEV1)
and peak expiratory £ow rate (PEFR). FEV% was calcu-
lated as FEV1in percentage of VC.Functional residual ca-
pacity (FRC) and residual volume (RV) were measured
with the single-breath nitrogenwashout technique.Total
lung capacity (TLC) was calculated as VC + RV.The sin-
gle-breath carbon monoxide di¡using capacity (DLCO)
was measured according to the method of Ogilvie et al.
(14). The patients were instructed to exhale slowly and
maximally to RV, and then rapidly inhale maximally to
TLC to ¢ll the lungs with the di¡usion gas. If the ¢rst
two e¡orts di¡ered by more than 10%, a third e¡ort
was attempted. Alveolar volumewasmeasuredbyNeondilution during the breath-holding manoeuvre. The
DLCO valueswere corrected for thepatient’s preopera-
tive haemoglobin (Hb) concentration using the equation
of Cotes et al. (15).
On the 4th postoperative day and 4 months post-
operatively, the patients were asked to quantify their
sternotomy wound pain at rest, while taking a deep
breath, while coughing and at the performance of the
pulmonary function test. A continuous unmarked visual
analogue scale (VAS) from0 (nopain) to10 (worst imagin-
able pain) was used.Patientswere also asked to state the
level of thorax pain (severe, moderate, little or no pain)
over the 4 months after surgery and their subjective ex-
perience of breathing (improved, unaltered, impaired)
compared to the preoperative status.
Statistical analysis
Postoperative pulmonary function values are reported
as absolute values and as % of the preoperative values.
The relative decrease of the pulmonary function vari-
ables after the operationwas calculated for eachpatient.
Postoperative values were compared by a paired t-test
with preoperative values. All results refer to two-sided
tests and a probability value less than 0.05 was consid-
ered signi¢cant.
RESULTS
In total, 25malepatients, aged 46^79 yearswere studied
before, 4 days and 4 months after CABG. Another ¢ve
patients were not available for the evaluation because
of stroke, abdominal surgery, walking problems or reluc-
tance. Demographic and surgical data are presented in
Tables1and 2.
Before the operation, the patients had normal lung
function related to the reference values (VC,91.5713.9%
of predicted and FEV1, 98.9720.8% of predicted). Static
lung volumes and DLCO could not be measured in two
and six patients, respectively, because of intolerable cali-
bration. Four days postoperatively, a severe restrictive
TABLE 2. Surgical data
Variables
Operationtime (h) 4.270.8
ECC (min) 111721
AoO (min) 58713
Totalnumberof anastomoses 6.271.2
LIMAgraft/RIMAgraft (n) 21/1
Left/bilateralpleural space entered (n) 16/4
Postoperativemechanicalventilation (h) 7.273.6
Values aremean7SD ornumberof patients.
ECC= extracorporeal circulation, AoO= aortic occlu-
siontime,LIMA= left internalmammary artery,RIMA= -
right internalmammary artery, n= numberof patients.
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in VC to 60.779.0% and in FEV1 to 64.6712.2% of pre-
operative values.
Four months after the operation, the VC, IC, FEV1,
PEFR, FRC, TLC and DLCO were still signi¢cantly re-
duced compared to preoperative values, while no signi¢-
cant abnormality was found in FEV%, RVand DLCO/VA
(Table 3). Four months after surgery, 11 patients experi-
enced breathing to be improved, 12 unchanged and two
patients claimed impaired breathing compared to the
preoperative status. The sternotomy pain was low 4
months postoperatively (Fig. I). In the 4 months period
after surgery, one patient stated severe thorax pain, se-
ven moderate,12 little and ¢ve patients reported no ex-
perienced pain.TABLE 3. Pulmonary function and pulmonary di¡using capac
months after CABG.
Preoperative Postoperativ
4 days
VC (l) 4.270.6 2.570.5
IC (l) 3.370.6 2.070.5
FEV1 (l) 3.070.7 1.970.5
FEV (%) 71.178.1 75.578.0
PEFR (l/min) 5407119 3617112
FRC (l) 3.170.8 2.470.6
RV (l) 2.270.6 1.770.4
TLC (l) 6.370.8 4.370.8
DLCO (ml/min(mmHg) 23.275.8 15.773.4
DLCO/VA (ml/min(mmHg/l) 3.870.9 3.870.9
Values aremean7SD.
*Statistical di¡erencesbetweenthe preoperative and the 4 mon
CABG= coronaryarterybypassgraft surgery,VC = vitalcapacit
1s, FEV% = FEV1 in percentage of VC, PEFR= peak expiratory £
lume,TLC= total lung capacity,DLCO= single-breath di¡using c
alveolar volume.DISCUSSION
A signi¢cantly reduced pulmonary function was found 4
months after CABG, in spite of normal preoperative va-
lues. All lung volumes apart from RV were reduced 6^
13% compared to the preoperative values.The decrease
was of the same extent as was found after open heart
surgery10^20 years ago inVC, IC, FRC and TLC (7) and
inVC, IC and FEV1(9).The changes in RV were found not
to be signi¢cant, which is the same result found 6 weeks
(16) and 3 months (9) after CABG.The reason for this is
unclear, but could be explained by a compensatory in-
crease in RVdue to airway closure and air£ow limitations
at low lung volumes, leading to incomplete emptying and
this could possibly conceal a restrictive defect.
After a 4month period, a decrease in pulmonary func-
tion is to be expected for reasons of ageing. According to
reference values (17), the normal reduction is for VC and
FEV1 about 20^30 and for FRC 10ml per year in non-
smokers, whileTLC is not a¡ected by age. For smokers,
a reduction inVC and FEV1 is about double; still this re-
duction is less than the reductions found in the present
investigation. In the investigation by Shenkman et al. (11),
a more pronounced decrease in pulmonary function is
described after cardiac surgery. No static lung volumes
or di¡usion capacity weremeasured, but the forced vital
capacity (FVC)was reducedby an average of 25% in FEV1
and PEFR 3^4 months after surgery. FEF50, FEF75 and
maximal voluntary ventilation did not recover at all 3.5
months postoperatively compared to 3 weeks after sur-
gery.This indicates thatpulmonary function after cardiac
surgery is long lasting, andmay even be permanent.ity data preoperatively, on the 4th postoperative day and 4
e Postoperative
4 months
Postoperative
4 months in %
of preoperative values
P-value*
3.770.7 88.379.3 o0.001
2.970.7 88.3715.1 o0.001
2.670.6 87.279.6 o0.001
70.177.7 98.977.4 0.35
4847115 89.679.9 o0.001
2.970.7 94.4716.3 0.05
2.070.6 95.5732.3 0.14
5.770.9 89.5712.0 o0.001
21.975.8 90.1711.8 o0.01
3.870.9 98.7712.5 0.41
thspostoperative values.
y,IC = inspiratorycapacity,FEV1 = forcedexpiratory volumein
ow rate, FRC= functional residual capacity,RV = residual vo-
apacity for carbonmonoxide and DLCO/VA=DLCOper unit
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FIG. 1. Box-and-whiskerplotsof sternotomyincisionpainmeasuredbyVASatrest, whiletakingadeepbreath, while coughingandat
the performance of the pulmonary function test reported on the 4th postoperative day and 4 months after CABG (n= 25).The box
indicatestherangebetweenthe 25thand 75thpercentiles; thelinemarks the 50thpercentile.Cappedbars (whiskers) indicatethe10th
and 90thpercentiles.Medianvalues (cm). VAS = visual analogue scale.
320 RESPIRATORYMEDICINEMany factors thatmay have an in£uence on the impair-
ment have been suggested. Altered mechanics after
opening of the thorax, reduced rib cage expansion and
uncoordinated chest wall motion may possibly persist
for several months. Both respiratory muscle weakness
and alterations in chest wall mechanics induced by sur-
gery may contribute to these changes (9,16,18). Basal at-
electasis develops early during anaesthesia and possibly
will persist into the postoperative period (19).The viola-
tion of the pleural space is also suggested as a reason for
the dysfunction. In the investigation by Landymore and
Howell (20),95% of 72 patients with the pleura left intact
during surgery had normal chest X-rays 3 months after
surgery.Of 34 patients having pleura opened during sur-
gery, 53%hadpersistent loss of left-lung volumerelated to
thepresence of left-lower-lobe atelectasis and signs of left
pleural e¡usions 3 months after surgery (20). Depressed
cardiac function and low cardiac output can lead to venti-
lation^perfusion mismatch and hypoxaemia.Vaidya et al.
(21) have described long-term respiratory outcome after
openmitral valve surgery and found that after 3 months,
spirometry was impaired in11of 31patients, despite hae-
modynamic and functional improvement. In addition, the
cardiopulmonary bypass procedure (21) has an in£uence
on pulmonary function. Occurrence of postperfusion
lung syndrome is described and occasionally patients will
develop acute respiratory distress syndrome. Secondary
to cardiac dysfunction, pulmonary oedema further may
deteriorate pulmonary function.
Another possible cause of these abnormalities is dia-
phragmatic failure. Because myocardial oxygen demand
decreases at lower temperatures, myocardial coolingandmaintenance of a low body temperature during sur-
gerygives cardiac protection.The application of cold car-
dioplegic solution and the use of ice slush has been
associated with postoperative phrenic nerve paralysis
and associated diaphragmatic dysfunction (22^24). One
month postoperatively,Dimopoulou et al. (24) described
that eight out of 10 patients still had decreased phrenic
nerve conduction latency time. Even 1 year postopera-
tively persistent diaphragm elevation noticed on chest
Roentgenograms have been described in 22% of cardiac-
operatedpatients by Curtis et al. (22) and 31% of patients
by Efthimiou et al. (23).
After 4 months, the DLCO was still signi¢cantly
decreased by 9% while DLCO/VA had returned to the
preoperative level. The DLCO was corrected for the
patients’ haemoglobin value and was calculated per unit
alveolar volume, which is recommended (25). If the re-
duction in DLCO is due solely to the reduction in lung
volume, then theDLCOwhen corrected for lungvolume
DLCO/VA is normal.The reduction in DLCO was at the
same extent as the reduction of lung volume and appar-
ently due to the loss of volume.
The mechanism for di¡usion impairment after heart
surgery is unclear but could be caused by pulmonary oe-
dema and accumulation of £uid in the interstitial spaces,
ventilation^perfusion mismatch or changes in haemo-
globin concentration. DLCO may as well be in£uenced
by decreased ventilation, pulmonary diseases (26) and a
reduction in alveolar perfusion consequent to poor car-
diac output and chronic heart failure (27).
Few data are available concerning postoperative
di¡usion capacity abnormalities in patients undergoing
PULMONARYFUNCTIONAFTERCABG 321cardiac surgery. In the investigation by Shapira et al. (9),
the preoperative DLCO were signi¢cantly lower than
predicted values and improved at 3months to a level sig-
ni¢cantly higher than the preoperative values.
Patients who undergo CABGhave postoperatively in-
cision pain, which may a¡ect lung volumes and airway
clearance. In this study, pain could not explain the de-
creased pulmonary function 4 months after CABG. Pain
assessments were made both at rest, with deep breath-
ing, coughing andwhile performing the pulmonary func-
tion test.Coughing was, not surprisingly, found to be the
most painful manoeuvre, but measured levels of pain
were generally low 4 months after the operation.
All patients received postoperative chest physiother-
apy, including early mobilization and deep-breathing ex-
ercises. No method of postoperative therapy has been
distinguished in preventing or treating these long-term
changes and it is not clari¢ed how long after surgery pa-
tients shouldbe recommended to continuebreathing ex-
ercises. Forshag (28) has suggested that a reasonable
end-point of performing breathing exercises is when the
patients’ pulmonary function has returned to the preo-
perative level or to a new stable baseline.
Clinical implications
The postoperative recovery of changes in respiratory
function is delayed for months. If there are permanent
alterations of respiratory function is not yet known.
The important question is if the signi¢cantly reduced
pulmonary function is of a clinically relevant degree.The
signi¢cantly reduced FRC (6%) 4months postoperatively
is maybe not a relevant problem for some patients, ex-
cept perhaps for those with serious pulmonary disease.
Further clinical trials are needed to the clinical impor-
tance of deteriorated pulmonary function. Risk factors
in the development of long-term postoperative changes
in pulmonary function are moreover important to de-
termine.
CONCLUSION
A signi¢cant restrictive decrease in pulmonary function
was still present 4 months after CABG. In this study
postoperatively incision pain measured by VAS was low
andcouldnotexplain the decreasedpulmonary function.
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